2-Bromo-4-methylpyridine-3-carbonitrile
CAS: 65996-02-3
Ref. 3D-FB148586
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
2-Bromo-4-methylpyridine-3-carbonitrile (BMC) is a competitive inhibitor of human immunodeficiency virus (HIV) that is used in the treatment of HIV/AIDS. BMC inhibits HIV's transcriptase enzyme and terminates the production of viral RNA by binding to its active site. It also has been shown to inhibit nevirapine, another HIV drug, from binding to its target site on the HIV transcriptase enzyme. This drug has a bromo group, which enhances its efficiency as an inhibitor. The crystallization of this compound was achieved through chemistry and the synthesis of acyclic pyridines.
Propriedades químicas
Consulta técnica sobre: 3D-FB148586 2-Bromo-4-methylpyridine-3-carbonitrile
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
